Clinical Trials Directory

Trials / Completed

CompletedNCT01471236

Evaluation of the Agili-C Biphasic Implant in the Knee Joint

Evaluation of the Agili-C Bi-phasic Implant Performances in the Repair of Cartilage and Osteochondral Defects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
65 (actual)
Sponsor
Smith & Nephew, Inc. · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the performance of the Agili-C implants. The study hypothesis is that Agili-C implants are effective in the treatment of focal cartilage and cartilage-bone joint surface defects.

Detailed description

Agili-C implant is a bi-phasic, porous resorbable tissue regeneration scaffold for the treatment of focal articular cartilage and for osteochondral defects. Up to 50 patients are to be included in the study. Patients suffering from isolated, single and focal cartilage or osteochondral defect at the knee joint are considered for study inclusion.

Conditions

Interventions

TypeNameDescription
DEVICEAgili-C Bi-phasic ImplantThe implantation site should be created in perpendicular manner to the articular cartilage. The surrounding tissue will be cleaned and scraped to prepare a clean site. The implant will be placed in the correct orientation (drilled channels pointing towards the joint side and chamfer towards the bone). The implant will be inserted gently in a pressed fit manner.
PROCEDUREmini-arthrotomyThe procedure will be conducted according to hospital practice. The implants will be positioned via open incision, depending on lesion location, and Investigator's final decision. Related treatments during the procedure should be recorded. Device positioning details medications and adverse events during the procedure will be recorded. MOCART (off-site), X-ray evaluation (off-site), ICRS Cartilage injury mapping system, Articular cartilage injury Classification and the Osteochondritis Dissecans classification will be recorded.

Timeline

Start date
2011-06-01
Primary completion
2018-11-19
Completion
2018-11-19
First posted
2011-11-15
Last updated
2025-03-06

Locations

9 sites across 8 countries: Croatia, Czechia, Hungary, Italy, Poland, Romania, Serbia, Slovenia

Source: ClinicalTrials.gov record NCT01471236. Inclusion in this directory is not an endorsement.